MaxCyte Inc
MXCT2.035USD
-0.005-0.25%
交易中 （美東）報價延遲15分鐘
216.35M總市值
虧損本益比TTM
關於 MaxCyte Inc 公司
MaxCyte, Inc. 是一家專注於細胞工程的公司，提供解決方案以促進細胞療法的發現、開發和商業化。該公司利用其細胞工程技術平臺來支持從事細胞療法的生物技術和製藥公司客戶的計劃。其 ExPERT 平臺基於其流式電穿孔技術，旨在支持不斷擴大的細胞療法市場，並可用於整個細胞療法領域，從發現和開發到下一代細胞藥物的商業化。ExPERT 系列產品包括四種儀器，即 ATx、STx、GTx 和 VLx；一系列專有相關處理組件或一次性用品；以及軟件協議，所有這些都由全球知識產權組合支持。該公司還通過 ONE-seq 和 GUIDE-seq 平臺爲基因編輯提供全面的脫靶風險評估解決方案。
公司簡介
公司代碼MXCT
公司名稱MaxCyte Inc
上市日期Mar 29, 2016
CEOMr. Maher Masoud, J.D.
員工數量114
證券類型Ordinary Share
年結日Mar 29
公司地址9713 Key West Avenue,
城市ROCKVILLE
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編20850
電話13015175556
網址https://www.maxcyte.com/
公司代碼MXCT
上市日期Mar 29, 2016
CEOMr. Maher Masoud, J.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Stanley C. (Stan) Erck
Mr. Stanley C. (Stan) Erck
Non-Executive Independent Director
Non-Executive Independent Director
298.33K
+10.85%
Mr. John Joseph Johnston
Mr. John Joseph Johnston
Non-Executive Independent Director
Non-Executive Independent Director
171.16K
+20.58%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
150.58K
+24.07%
Ms. Rekha Hemrajani
Ms. Rekha Hemrajani
Non-Executive Independent Director
Non-Executive Independent Director
50.58K
+136.71%
Dr. Yasir B. Al-Wakeel
Dr. Yasir B. Al-Wakeel
Non-Executive Independent Director
Non-Executive Independent Director
50.58K
+136.71%
Mr. Douglas J. (Doug) Swirsky
Mr. Douglas J. (Doug) Swirsky
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Ms. Cynthia L. Collins
Ms. Cynthia L. Collins
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Maher Masoud, J.D.
Mr. Maher Masoud, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. William W. (Will) Brooke, J.D.
Mr. William W. (Will) Brooke, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ali Soleymannezhad
Mr. Ali Soleymannezhad
Chief Commercial Officer
Chief Commercial Officer
--
-100.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Stanley C. (Stan) Erck
Mr. Stanley C. (Stan) Erck
Non-Executive Independent Director
Non-Executive Independent Director
298.33K
+10.85%
Mr. John Joseph Johnston
Mr. John Joseph Johnston
Non-Executive Independent Director
Non-Executive Independent Director
171.16K
+20.58%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
150.58K
+24.07%
Ms. Rekha Hemrajani
Ms. Rekha Hemrajani
Non-Executive Independent Director
Non-Executive Independent Director
50.58K
+136.71%
Dr. Yasir B. Al-Wakeel
Dr. Yasir B. Al-Wakeel
Non-Executive Independent Director
Non-Executive Independent Director
50.58K
+136.71%
Mr. Douglas J. (Doug) Swirsky
Mr. Douglas J. (Doug) Swirsky
Chief Financial Officer
Chief Financial Officer
--
-100.00%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
業務USD
名稱
營收
佔比
Product sales
5.32M
51.16%
Licenses
4.68M
45.01%
other
397.00K
3.82%
地區USD
名稱
營收
佔比
Inside the United States
8.03M
77.32%
Outside the United States
2.36M
22.68%
業務
地區
業務USD
名稱
營收
佔比
Product sales
5.32M
51.16%
Licenses
4.68M
45.01%
other
397.00K
3.82%
股東統計
更新時間: 7月24日 週四
更新時間: 7月24日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Cadian Capital Management LP
9.42%
BlackRock Institutional Trust Company, N.A.
6.97%
The Vanguard Group, Inc.
5.23%
Vitruvian Partners LLP
4.74%
Mirabella Financial Services LLP
3.48%
Other
70.16%
持股股東
持股股東
佔比
Cadian Capital Management LP
9.42%
BlackRock Institutional Trust Company, N.A.
6.97%
The Vanguard Group, Inc.
5.23%
Vitruvian Partners LLP
4.74%
Mirabella Financial Services LLP
3.48%
Other
70.16%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
24.01%
Investment Advisor
23.62%
Hedge Fund
14.89%
Private Equity
4.83%
Research Firm
3.90%
Individual Investor
1.42%
Bank and Trust
0.71%
Pension Fund
0.16%
Insurance Company
0.03%
Other
26.41%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
294
78.23M
73.51%
-18.98M
2025Q1
308
82.56M
77.59%
-14.89M
2024Q4
308
80.42M
75.91%
-14.30M
2024Q3
300
80.65M
76.72%
-18.62M
2024Q2
297
80.25M
76.66%
-17.97M
2024Q1
302
79.09M
75.86%
-22.52M
2023Q4
303
79.97M
77.01%
-14.24M
2023Q3
292
77.05M
74.47%
-17.27M
2023Q2
284
79.82M
77.43%
-11.81M
2023Q1
275
80.19M
77.98%
-11.53M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Cadian Capital Management LP
10.03M
9.42%
+683.30K
+7.31%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
7.41M
6.97%
+63.83K
+0.87%
Mar 31, 2025
The Vanguard Group, Inc.
5.57M
5.23%
+135.98K
+2.50%
Mar 31, 2025
Vitruvian Partners LLP
5.04M
4.74%
--
--
Mar 31, 2025
Mirabella Financial Services LLP
3.70M
3.48%
--
--
Mar 31, 2025
Morgan Stanley Investment Management Inc. (US)
3.55M
3.34%
-547.43K
-13.36%
Mar 31, 2025
Morgan Stanley & Co. LLC
3.44M
3.23%
+3.16M
+1117.21%
Mar 31, 2025
Mudita Advisors LLP
3.33M
3.13%
+105.03K
+3.26%
Mar 31, 2025
River Global Investors LLP
3.25M
3.06%
+1.19M
+57.73%
Dec 31, 2024
Fidelity Management & Research Company LLC
2.75M
2.59%
-180.54K
-6.15%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.41%
iShares Micro-Cap ETF
0.05%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
Avantis US Small Cap Equity ETF
0.02%
iShares Russell 2000 Value ETF
0.02%
iShares Biotechnology ETF
0.02%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.41%
iShares Micro-Cap ETF
佔比0.05%
Invesco Nasdaq Biotechnology ETF
佔比0.03%
ProShares Ultra Nasdaq Biotechnology
佔比0.03%
Avantis US Small Cap Equity ETF
佔比0.02%
iShares Russell 2000 Value ETF
佔比0.02%
iShares Biotechnology ETF
佔比0.02%
Proshares Ultra Russell 2000
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
